Testing effectiveness (Phase 2)Ended earlyNCT04379518
What this trial is testing
Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients
Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSymptomatic COVID-19 Infection Laboratory-Confirmed
Roswell Park Cancer Institute 4